PSUSA/00009099/202204 - periodic safety update report single assessment

Cefuroxime axetil

About

Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.

Key facts

• Active substance(s) in scope of the PSUSA procedure:
  Cefuroxime axetil
• Procedure number:
  PSUSA/00009099/202204
• Regulatory outcome:
  Variation

Documents

Cefuroxime axetil - List of nationally authorised medicinal products - PSUSA/00009099/202204

Reference Number: EMA/794434/2022

Cefuroxime axetil - Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation - PSUSA/00009099/202204